Investigational targeted therapies for the treatment of testicular germ cell tumors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational targeted therapies for the treatment of testicular germ cell tumors
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 9, Pages 1033-1043
Publisher
Informa UK Limited
Online
2016-06-10
DOI
10.1080/13543784.2016.1195808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors.
- (2017) Costantine Albany et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib monotherapy in patients with inoperable/recurrent germ cell tumors (GCT) refractory to chemotherapy: Phase II study.
- (2017) Iwona Anna Skoneczna et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of pazopanib in chemo-resistant patients with germ cell tumors (GCT): First results of the open-label, single-group, phase II PAZOTEST-01 trial.
- (2017) Patrizia Giannatempo et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR).
- (2017) Darren Richard Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of nintedanib in germ cell tumors
- (2016) Gustav Steinemann et al. ANTI-CANCER DRUGS
- An open-label, single-group, phase 2 study of brentuximab vedotin as salvage therapy for males with relapsed germ-cell tumors (GCT): Results at the end of first stage (FM12GCT01).
- (2016) Andrea Necchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of everolimus in refractory testicular germ cell tumors
- (2016) Michal Mego et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
- (2015) Z. Cierna et al. ANNALS OF ONCOLOGY
- Frequent PD-L1 expression in testicular germ cell tumors
- (2015) C D Fankhauser et al. BRITISH JOURNAL OF CANCER
- Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas
- (2015) Ioana Cutcutache et al. EUROPEAN UROLOGY
- Reply to L.C. Pagliaro et al
- (2015) Darren R. Feldman JOURNAL OF CLINICAL ONCOLOGY
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- Current chemotherapeutic approaches for recurrent or refractory germ cell tumors
- (2015) Brent O׳Carrigan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Targeted therapies in germ cell tumors
- (2015) Christian M. Squillante et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors
- (2014) David J. Vaughn et al. CANCER
- Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors
- (2014) D. R. Feldman et al. CLINICAL CANCER RESEARCH
- Cisplatin resistance in germ cell tumours: models and mechanisms
- (2014) C. Jacobsen et al. Andrology
- Phase II Clinical Trial of Oxaliplatin and Bevacizumab in Refractory Germ Cell Tumors
- (2013) Amit Jain et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
- (2013) Mercè Juliachs et al. BMC CANCER
- The PDGFRβ–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
- (2013) M. Juliachs et al. CLINICAL CANCER RESEARCH
- Long-term survival in patients with germ cell testicular cancer: A population-based competing-risks regression analysis
- (2013) G. Gandaglia et al. EJSO
- Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data
- (2013) Charlotte Le Cornet et al. EUROPEAN JOURNAL OF CANCER
- Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer
- (2013) R. Koster et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor
- (2013) M. Juliachs et al. INTERNATIONAL JOURNAL OF CANCER
- Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors
- (2013) Francesca Cavallo et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors
- (2013) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Precision Oncology: An Overview
- (2013) Levi A. Garraway et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP expression in germ cell tumours
- (2013) Michal Mego et al. JOURNAL OF CLINICAL PATHOLOGY
- Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment
- (2013) Patrizia Giannatempo et al. JOURNAL OF UROLOGY
- Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing
- (2013) Christian G. Ruf et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
- (2012) B Nitzsche et al. BRITISH JOURNAL OF CANCER
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Prognostic Impact of the Cancer Stem Cell–Related Marker NANOG in Ovarian Serous Carcinoma
- (2012) Maria Lee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
- (2012) A Lopez-Girona et al. LEUKEMIA
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- Prognostic significance of NANOG and KLF4 for breast cancer
- (2012) Takuya Nagata et al. Breast Cancer
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- Pluripotency Factors in Embryonic Stem Cells Regulate Differentiation into Germ Layers
- (2011) Matt Thomson et al. CELL
- Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation
- (2011) Mingxuan Xia et al. CELL CYCLE
- Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
- (2011) Karin Oechsle et al. EUROPEAN UROLOGY
- Targeting the missing links for cancer therapy
- (2011) Kornelia Polyak et al. NATURE MEDICINE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
- (2011) R Koster et al. Cell Death & Disease
- p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors
- (2010) Baozong Li et al. CELL CYCLE
- Targeting the RB-pathway in Cancer Therapy
- (2010) E. S. Knudsen et al. CLINICAL CANCER RESEARCH
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Analysis of Gene Expression Profiles of Microdissected Cell Populations Indicates that Testicular Carcinoma In situ Is an Arrested Gonocyte
- (2009) S. B. Sonne et al. CANCER RESEARCH
- Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors
- (2009) D. Rathkopf et al. CLINICAL CANCER RESEARCH
- Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
- (2009) W. Castillo-Avila et al. CLINICAL CANCER RESEARCH
- Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
- (2009) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors
- (2009) Karin Oechsle et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Microsatellite Instability, Mismatch Repair Deficiency, andBRAFMutation in Treatment-Resistant Germ Cell Tumors
- (2009) Friedemann Honecker et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Growing Teratoma Syndrome
- (2009) David J. Vaughn et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Mutations of c-kit gene in bilateral testicular germ cell tumours in Japan
- (2007) Yuji Sakuma et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search